- Johnson & Johnson said on Nov. 12 that it is planning to break into two companies, splitting off its consumer health division, which sells Band-Aids and Baby Powder, from the large pharmaceuticals unit that makes cancer drugs and vaccines.
- The company will separate its consumer health business into a new publicly traded company and is aiming to complete the planned separation in 18 to 24 months, it said in a statement. Column by Aimee Donnellan in London and Robert Cyran in New York. Editing by Rob Cox and Oliver TaslicReuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.